Given the high risk of malignancies associated with PSC-IBD, it is critical to identify patients at high risk and implement appropriate surveillance and monitoring strategies. The authors provide an overview of PSC-IBD, which exemplifies the gut–liver axis.
[Experimental & Molecular Medicine]